Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Closed-Loop Decoding and Intervention of Pain: A Novel BMI Strategy Integrating θ-Band Detection and Mechano-Electro-Biological Coupled Hydrogels.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Omphalocele-exstrophy-imperforate anus-spinal defect syndrome in a monozygotic twin pregnancy: a case report and literature review.

BMC pregnancy and childbirth·2026

Same author

Latent transition analysis of home-based fluid management during the vulnerable phase in patients with chronic heart failure: impact on symptom burden.

Frontiers in cardiovascular medicine·2026

Same author

Flavor Formation Mechanisms and Modulation Strategies in Plant-Based Cheese Analogs: From Raw Material Selection to Technological Innovations.

Comprehensive reviews in food science and food safety·2026

Same author

Topology-Driven Activation of the GLP-1 Receptor Promotes Adipose Tissue Browning.

Protein & cell·2026

Same author

Factors associated with clinical leadership among cardiovascular nurses in China: a multicentre cross-sectional study.

Annals of medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Management insulin dosing for diabetes using a partially observable Markov decision process with missing data

Jiao Xiang¹, Haiyan Yu², Li Luo¹

¹Business School, Sichuan University, 1st Ring Road, Sichuan Chengdu, 610065, China.

Scientific Reports

|June 17, 2026

Summary

Missing data in continuous glucose monitoring (CGM) impacts diabetes management. Temporally informed imputation methods, like adjusted M-H, better preserve CGM data and decision-making policies compared to simple mean imputation.

Keywords:

Bridge-based adjusted Metropolis-Hastings algorithm Continuous glucose monitoring Missing data imputation Partially observable Markov decision process Policy disagreement

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Related Experiment Videos

Last Updated: Jun 19, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Area of Science:

Biomedical Engineering
Data Science
Diabetes Technology

Background:

Missing data in continuous glucose monitoring (CGM) hinders effective diabetes management using sequential decision-making models.
Partially Observable Markov Decision Processes (POMDPs) are crucial for optimizing diabetes care but are sensitive to data gaps.

Purpose of the Study:

To evaluate the impact of different missing-data imputation methods on downstream POMDP-based policy outputs for diabetes management.
To compare mean imputation, linear interpolation, and an adjusted Metropolis-Hastings (M-H) algorithm in handling missing CGM data.

Main Methods:

Utilized real CGM trajectories from the Stanford CGM Database.
Compared three imputation methods: mean, linear interpolation, and adjusted M-H algorithm with temporal and smoothness constraints.
Assessed performance using mean squared imputation error (MSIE), policy disagreement rate, and absolute reward gap under random and block missingness scenarios.

Main Results:

Mean imputation resulted in significantly higher reconstruction errors and downstream POMDP deviations.
Linear interpolation and adjusted M-H preserved CGM trajectories and POMDP policies more effectively than mean imputation.
Adjusted M-H demonstrated advantages in nonlinear trajectories and block missing segments, showing comparable POMDP performance.

Conclusions:

Temporally informed imputation methods are superior to mean imputation for incomplete CGM data in diabetes management.
The adjusted M-H algorithm offers a model-compatible imputation strategy for preserving sequential decision outputs with partially observed glucose data.